Wafik El-Deiry: Good turnout by colleagues to the CNS Tumors session at ASCO24
Wafik El-Deiry recently shared on LinkedIn:
“Good turnout by colleagues to the CNS Tumors session and glad quite a few stopped by our poster on Therapeutic insights for the aggressive subset of High-Grade Gliomas (HGG) driven by chromosome 1q32 MDM4-containing amplicon and unmethylated MGMT.”
Source: Wafik El-Deiry/LinkedIn
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School Director of the Legorreta Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry made important contributions to cell death signaling and our understanding of the sensitivity of tumors to chemotherapy. El-Deiry has more than 400 peer-reviewed publications and 5 edited books.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023